Page last updated: 2024-09-04

docetaxel anhydrous and darinaparsin

docetaxel anhydrous has been researched along with darinaparsin in 1 studies

Compound Research Comparison

Studies
(docetaxel anhydrous)
Trials
(docetaxel anhydrous)
Recent Studies (post-2010)
(docetaxel anhydrous)
Studies
(darinaparsin)
Trials
(darinaparsin)
Recent Studies (post-2010) (darinaparsin)
12,1103,2166,92033921

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bansal, N; Bertino, JR; Farley, NJ; Lewis, J; Wu, L; Youssoufian, H1

Other Studies

1 other study(ies) available for docetaxel anhydrous and darinaparsin

ArticleYear
Darinaparsin inhibits prostate tumor-initiating cells and Du145 xenografts and is an inhibitor of hedgehog signaling.
    Molecular cancer therapeutics, 2015, Volume: 14, Issue:1

    Topics: Animals; Antineoplastic Agents; Arsenicals; Cell Cycle; Cell Line, Tumor; Docetaxel; Dose-Response Relationship, Drug; Drug Synergism; Gene Expression Regulation, Neoplastic; Glutathione; Hedgehog Proteins; Humans; Kruppel-Like Transcription Factors; Male; Mice; Neoplastic Stem Cells; Nuclear Proteins; Prostatic Neoplasms; Signal Transduction; Taxoids; Xenograft Model Antitumor Assays; Zinc Finger Protein Gli2

2015